As a consequence of Pietrek Associates reputation in the safety area as well as in phase I-IV interventional and non-interventional studies, we have been asked to carry out several due diligence and competitor review projects.
Key Deliverables
Review of client’s growth strategy, revenue and profit projections
Provision of perspectives on current phase IV and pharmacovigilance market/landscape issues and considerations for merger & acquisition activities
Identification of potential acquisition targets and recommended implementation/growth strategy
Joint selection of targets for detailed analyses and subsequent due diligence
